Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Find out which savings strategy is most effective for your financial goals. Implement these strategies for better savings.
26,213 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Symbotic's shiny narrative has investors buzzing, but the biggest gains often hinge on real execution, not just optim...
Lawmakers reached an in-principle agreement on stablecoin-yield provisions within the CLARITY Act, a move that could ...
Global fertilizer supply disruptions push prices higher, threatening farm budgets and consumer costs in the United St...
Tower Semiconductor is navigating a critical inflection point as it scales SiPho production and expands in Japan, wit...
As the nation nears its Semiquincentennial, a bold campaign seeks to make July 4, 2026 the largest day of charitable ...
Himax (HIMX) faces a pivotal year as AR/VR, automotive displays, and smartphone drivers shape demand. This Q1 2026 ea...
SVB Capital, a 110-person venture arm once tied to SVB Bank, is in limbo after regulators seized the parent bank. A p...
A major institutional move in a global bond ETF highlights how fixed-income ballast can stabilize portfolios during r...
Brokerage consolidations are shifting leverage toward agents as new split and autonomy models emerge. This report exa...
A wave of healthcare AI players trading under $50 is drawing attention for real progress in partnerships and revenue....
GE Vernova reports $18.3 billion in Q1 2026 orders and a $150 billion backlog, underscoring a durable AI-driven capex...